For Company Research, enter symbol or keyword and choose type of research:    Symbol Search
Iovance Biotherapeutics Inc
(NASDAQ: IOVA) Add to Portfolio
$21.61
-0.80 (-3.57%)
as of Jun 21, 2019

Last 21.61
Change -0.80 (-3.57%)
Open 22.23
Prev. Close 22.41
Today's Range
20.63 22.23
52wk Range
7.26 23.26
Volume 4,177,900
Avg Volume 2,247,295
Sector SIC-2836 Biological Products, (No Disgnostic Substanc

Recent Headlines
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it has entered into a lease agr (full story)
IOVA: 21.61 (-0.80), JLL: 139.55 (-1.14)
InvestorsObserver issues critical PriceWatch Alerts for ACB, AMAT, IOVA, NVDA, and UAA. (full story)
AMAT: 43.02 (+0.06), NVDA: 152.35 (+0.59), ACBFF: 8.6900 (-1.2758), IOVA: 21.61 (-0.80), UAA: 26.15 (-0.43)
Patients with advanced cervical cancer treated with LN-145 had an objective response rate of 44 percent (full story)
IOVA: 21.61 (-0.80)
- First patient dosed in pivotal Cohort 4 in study of lifileucel in advanced melanoma; regulatory submission planned for late 2020 - (full story)
IOVA: 21.61 (-0.80)
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that the company plans to participat (full story)
IOVA: 21.61 (-0.80)
 
Performance Comparison
Name Today 3-Month 1-Year
IOVA -3.57% +85.02% +64.33%
Growth Rates
YTD +144.18%
1-Year +58.90%
3-Year +174.94%
5-Year +243.02%
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. SEC Filings provided by Edgar Online. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.